• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Molecular mechanisms of ferroptosis and its role in the treatment of breast cancer

    2024-03-26 12:55:16JINGBoCHENHengyuWUHuangfu
    Journal of Hainan Medical College 2024年1期

    JING Bo, CHEN Heng-yu, WU Huang-fu?

    1. The Second Clinical College of Hainan Medical University, Haikou 571199, China

    2. Department of Breast & Thyroid Surgery, the Second Affiliated Hospital of Hainan Medical University, Haikou 570311, China

    Keywords:

    ABSTRACT Breast cancer is a critical threat to women around the globe.Current radio- and chemotherapy regimens can induce multiple drug-resistant effects, e.g., anti-apoptosis, anti-pyroptosis,and anti-necroptosis, causing a poor clinical response to therapy.Ferroptosis is a newly programmed cell death characterized by iron overload, the massive production of reactive oxygen species (ROS), and membrane lipid peroxidation.The occurrence of ferroptosis results from an imbalance between peroxidation mechanisms (execution systems) and antioxidation mechanisms (defense systems), including the iron metabolism pathway, amino acid metabolism pathway, and lipid metabolism pathway.Recently, the vital role of ferroptosis in various diseases, including cancer, hypertension, diabetes, and Alzheimer's, has been identified.Specifically, triggering ferroptosis in breast cancer cells can inhibit their proliferation and invasion, and improve the chemoradiotherapy sensitivity, which makes it a potential strategy for breast cancer therapy.This review summarizes the definition and features of ferroptosis,as well as its role in the treatment of breast cancer, aimed at providing a theoretical basis for future drug development.

    Breast cancer is the most common malignant tumor in women with a high fatality rate.According to the study of Harbeck et al., there are about 17 million newly diagnosed cases of breast cancer worldwide every year, and 5 million women die from this disease[1].Clinically, the main therapeutic methods for this disease include surgical resection, chemoradiotherapy, endocrine therapy,immunotherapy and targeted therapy.However, due to its high degree of malignancy and susceptibility to drug resistance, the prognosis of breast cancer patients is generally not ideal[2].In recent years, programmed cell death modes, such as apoptosis, necrosis,autophagy, pyrodeath and necrotic apoptosis, have been found to be closely related to the proliferation, migration and drug resistance of breast cancer cells[3].ferroptosis, a concept proposed by Dixon et al in 2012, is an iron-dependent, non-apoptotic programmed cell necrosis, mainly manifested by reactive oxygen species (ROS)accumulation and membrane lipid peroxidation damage, which ultimately leads to cell death[4].ferroptosis has been confirmed to enhance the sensitivity of breast cancer to radiotherapy and chemotherapy, inhibit the growth of breast cancer tissues, distant metastasis and recurrence of cancer tissues, etc., which makes the induction of ferroptosis a potential strategy for the treatment of breast cancer[5].This paper focuses on the mechanism of ferroptosis and its role in the treatment of breast cancer to provide theoretical support for further improvement of breast cancer treatment and targeted drug development.

    1.Characteristics of ferroptosis

    Ferroptosis is different from the known programmed cell death in morphological, biochemical and genetic aspects.Morphologically,the most prominent feature was the change of mitochondrial ultrastructure, which was manifested as obvious atrophy of mitochondria, increased membrane density and decreased or disappeared mitochondrial cristae, while the nucleus was normal in size and the nuclear chromatin was not condensed.In terms of biochemical characteristics, when ferroptosis occurs, intracellular iron and ROS levels are significantly increased, glutathione (GSH)is consumed, glutathione peroxidase 4 (GPX4) is inactivated and mitochondrial membrane potential is reduced[6].From the perspective of mechanism, several previously discovered programmed cell death are execution-centered.For example,apoptosis is mainly executed by the caspases family, pyroptosis is mainly executed by the gasdermins family, and necroptosis is mainly mediated by mixed-lineage kinase domain-like protein (MLKL)[7].As a unique mode of cell death, ferroptosis depends on the confrontation between the execution system and the defense buffer system[8].Its implementation mechanisms include iron accumulation,Fenton reaction, synthesis and peroxidation of Polyunsaturated fatty acid-phospholipid (PUFA-PLs), etc.The defense mechanism is mainly System Xc-/GSH/GPX4 system[9, 10].The mechanism by which ferroptosis occurs is shown in Figure 1.

    In addition, two non-classical antioxidant systems, FSP1-CoQH2 system and DHODH-CoQH2 system, are also generally recognized[11].

    Fig 1 Mechanisms of ferroptosis

    2.Ferroptosis regulates pathways for breast cancer therapy

    Breast cancer is the most common malignant tumor in Chinese women.At present, the treatment methods for breast cancer mainly include surgery, radiotherapy and chemotherapy, endocrine therapy and targeted therapy.Although some achievements have been made,drug resistance and radiotherapy insensitivity often occur in the later stage, making the prognosis of breast cancer patients not ideal.In recent years, studies have confirmed that a variety of drugs, active compounds and related nanomaterials can inhibit the growth of breast cancer tissues, enhance the sensitivity of cancer tissues to radiotherapy and chemotherapy, and inhibit the distant metastasis and recurrence of breast cancer by inducing ferroptosis, which makes the induction of ferroptosis a potential strategy for the treatment of breast cancer[11].The pathways by which ferroptosis regulates breast cancer treatment and drug resistance are shown in Table 1

    2.1 Accumulation of iron

    Circulating Fe3+can combine with transferrin (TF) to form TFFe3+complex, which is endocytosed to the cell through transferrin receptor 1 (TFR1) on the cell membrane surface and localized tothe endosome.In the endosome, Fe3+is reduced to Fe2+by the sixtransmembrane epithelial antigen of prostate 3 (STEAP3), which is released into the labile iron pool (LIP) of the cytosol with the help of divalent metal ion transporter 1 (DMT1).A part of intracellular Fe2+can combine with ferritin heavy chain (FTH1), be oxidized to Fe3+, and then bind to ferritin light chain (FTL) to form ferritin complex stored in the cell.When the intracellular Fe2+content is significantly increased, too much iron will combine with hydrogen peroxide (H2O2) to produce Fenton reaction.The generation of hydroxyl free radicals ( OH) with strong oxidation ability increases the intracellular ROS level, and further promotes the peroxidation of PUFA-PLs under the synergistic effect of ester oxygenase (LOX),leading to cell membrane rupture and ferroptosis[12].Tyrosine kinase inhibitor neratinib is a commonly used chemotherapeutic drug for the treatment of HER-2+ breast cancer patients.It can increase the expression of TFR1 in cancer cells, induce iron accumulation and ferroptosis, and inhibit brain metastasis of cancer tissues in vivo[13].Similarly, the synergistic anticancer effect of chemotherapy drugs siramesine and lapatinib can increase TF content, promote intracellular iron accumulation, and induce ferroptosis in TNBC cells to exert synergistic anticancer effect[14].

    Tab 1 Pathways by which ferroptosis regulates Breast cancer therapy

    Liu et al.found that transmembrane protein 189 (TMEM189) can inhibit autophagy of TNBC cancer cells, reduce TFR1 expression and intracellular lipic-ROS content, alleviate ferroptosis, and promote the growth of breast cancer in vivo[15], suggesting that TMEM189 inhibitors may have a good therapeutic effect on TNBC.Iron-saturation lactoferrin (Holo-Lf) combined with radiotherapy at a dose of 4 Gy can significantly enhance the ferroptosis induced by Erastin in TNBC, inhibit the proliferation and migration of cancer cells, and enhance the radiosensitivity[16].Shuganning injection(SGNI), a Chinese patent drug, can selectively up-regulate the expression of heme oxygenase-1 (HO-1) in TNBC cells, promote iron accumulation and ferroptosis in LIP, and inhibit the growth of breast cancer tissues in vitro and in vivo[17].Artemisinin can promote ferritinophagy, increase intracellular Fe2+content and ferroptosis in TNBC cells, enhance the sensitivity of cancer tissue to ferroptosis inducer RSL3, and inhibit the development of breast cancer in vivo[18].Holo-Lf, SGNI and artemisinin are promising candidates for the treatment of TNBC.

    In recent years, there have also been many reports on nanoparticles targeting breast cancer therapy by iron accumulation and ferroptosis mechanism.Xu et al.developed a Fe2+-based nanoorganic metal framework (MOF-Fe2+), which can efficiently deliver Fe2+to breast cancer cells, promote the Fenton reaction and the generation of large amount of ROS, induce ferroptosis, and effectively inhibit the growth of breast cancer tissues in vivo[19].Zhu et al.constructed a Fe3+ cross-linked nanoparticle loaded with trans-azo-conpratin(trans-Azo-CA4), which can specifically enter breast cancer cells.After being excited by infrared light, the loaded Fe3+is converted to Fe2+,triggering Fenton reaction and lipid peroxide accumulation,and inducing ferrodeath of cancer cells.After the application of this particle in mice, the volume of breast cancer was significantly reduced and the anti-tumor effect was good[20].Zhang et al.designed a cascade of heparanase-driven release nanoparticles loaded with doxorubicin (Dox), ferrocene (Fc), and TGF-β receptor inhibitor SB431542.After entering breast cancer cells, the nanoparticles can increase intracellular iron accumulation and ROS content through Dox and Fc, activate ferroptosis, and successfully prevent cancer tissue metastasis in mice [21].The efficacy of these nanoparticles in clinical application needs to be further confirmed.

    2.2 System Xc-/GSH/GPX4

    The System Xc-/GSH/GPX4 system is the most important antioxidant defense mechanism for ferroptosis[22].GPX4 is a GSHdependent key enzyme that cleans intracellular lipid-ROS, converts reduced GSH to oxidized GSH (GSSG), and degrades phospholipid hydroperoxides (PLOOH) to non-toxic fatty alcohols to maintain the homeostasis of membrane Lipid bilayer, which is a key step to inhibit ferroptosis[23].The vast majority of intracellular GSH is synthesized from glutamate, cysteine and glycine by catalytic enzymes.The glutamate-cystine reverse transport system (system Xc-) is the way for most cells to obtain cysteine.This system is composed of disulfide bonded heterodimers SLC7A11 and SLC3A2,which can transport intracellular glutamate to the outside of the cell and extracellular cystine to the inside of the cell at a ratio of 1:1[24].Inhibiting the activity of System Xc-/GSH/GPX4 axis is an effective way to prevent the growth of breast cancer and treat breast cancer.

    2.2.1 GPX4

    Clinical studies have found that dihydroisotanshinone Ⅰ, the active component of salvia miltiorrhiza, can inhibit the expression of GPX4 in breast cancer cells, promote ferroptosis, and inhibit the growth of tumor tissues in mice without showing significant side effects[25].DMOCPTL, a derivative of natural product parthenolide, can directly bind to GPX4 protein to promote GPX4 ubiquitination and induce ferroptosis in breast cancer cells.In vivo, DMOCPTL can effectively inhibit the growth of mouse mammary tumors and significantly prolong the life span of mice without obvious toxicity[26].Wen et al.extracted the active compound glycyrrhetinic acid from the traditional herb licorice, and found that it could reduce the activities of GSH and GPX4, aggravate lipid peroxidation, and induce ferroptosis in breast cancer cells[27].Metformin can up-regulate the level of miR-324-3p in TNBC cells, target inhibition, promote ferroptosis, and significantly reduce the growth of cancer tissues in vivo[28].In addition, Jaggupilli et al.found that V9302, a small molecule compound that inhibits glutamine uptake, induces lipid peroxidation and promotes ferroptosis in TNBC cells by significantly inhibiting GSH and GPX4 activities in SUM159 and MDA-MB-231 cells.In vitro and in vivo combined with paclitaxel can significantly inhibit the growth of breast cancer[29].Dihydroisotanshinone Ⅰ, DMOCPTL, glycyrrhetinic acid, metformin and V9302 may be effective potential drugs for the treatment of breast cancer.

    Yao et al.reported that simvastatin (SIM) can attenuate 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) activity to inhibit mevalonate (MVA) pathway and GPX4 expression, thereby inducing ferroptosis in TNBC cancer cells.They further loaded SIM into zwitzwitzonic polymer-coated magnetic nanoparticles (Fe3O4@PCBMA) and achieved good anti-breast cancer effect in vivo.At present, Fe3O4 has been proved to be clinically available by the US Food and Drug Administration (FDA), and Fe3O4@PCBMA-SIM nanosystems may have great potential for clinical application[30].

    2.2.2 GSH

    Li et al.found that tumor-associated macrophages (TAMs)can secrete transforming growth factor β1 (TGF-β1) and upregulate the expression of hepatic leukemia factor (HLF) in TNBC cells, which makes breast cancer tissue larger and less sensitive to chemotherapy drug cisplatin.Mechanistically, HLF transcriptionally activates γ-glutamyl transpeptidase (GGT1), which catalyzes the cleavage of extracellular GSH and increases GSH content in cancer cells, thereby inhibiting ferroptosis and enhancing the proliferation and invasion ability of TNBC cells and the resistance of cancer tissues to cisplatin[31].Zou et al.identified fibroblast growth factor receptor 4 (FGFR4) as an essential gene for the acquisition of drug resistance in HER2+ breast cancer, and inhibition of FGFR4 in mice in vivo reduced GSH synthesis and Fe2+efflux efficiency through the β-catenin/TCF4-SLC7A11/FPN1 axis.It leads to excessive ROS production, iron accumulation and ferroptosis in LIP, and enhances the sensitivity of drug-resistant HER2+ breast cancer to chemotherapeutic drugs[32].HLF and FGFR4 may be the targets of drug development for the prevention and treatment of breast cancer.New breast cancer prevention and treatment materials targeting GSH and ferroptosis have also been reported in recent years.A sonodynamic sensitizer containing platinum (ii) -indocyanine complex can enhance the sensitivity of cancer tissue to ultrasound radiation therapy by reducing GSH content in TNBC cell line 4T1,promoting ROS generation and ferroptosis[33].Zhou et al.used cinnamaldehyde as a material to make a dimer capable of consuming GSH.When combined with sorafenib, this dimer significantly enhanced ferroptosis of 4T1 cancer cells and successfully cured breast cancer in mice in vivo by promoting dendritic cell maturation and CD8+T cell priming[34].

    2.2.3 System Xc-

    Actin-binding protein 1 (fascin) can directly bind to System Xc-,degrade System Xc- through the ubiquitin-proteasome system,enhance the sensitivity of MCF7 cells to Erastin, and inhibit the growth of breast cancer in vivo[35].The chemotherapeutic drug sulfasalazine can promote ferroptosis of breast cancer cells by specifically inhibiting the function of SLC3A1, and the use of this function to treat breast cancer has been in phase II clinical trials[36].Metformin can inhibit the UFMylation modification of SLC7A11,down-regulate the expression of SLC7A11, promote the ferroptosis of TNBC cancer cells, reduce the volume of breast cancer in vivo,and the effect is better when combined with sulfasalazine[37].Isoglycyrrhizin can inhibit the NF-κB signaling pathway in MDAMB-231 and MCF-7 cells, reduce the expression of System Xc-,promote ferroptosis, and reduce the resistance of breast cancer tissue to doxorubicin[38].Trastuzumab can increase the expression of circular RNA BGN (circ-BGN) in breast cancer cells BT474 and SKBR3, enhance the deubiquitination and expression of SLC7A11,inhibit ferroptosis, and induce drug resistance in cancer tissues,which can be reversed by Erastin[39].

    2.3 ACSL4

    The synthesis and peroxidation of PUFA-PLs is a prerequisite and key step for ferroptosis.Compared with monounsaturated fatty acids(MUFA), there are easily oxidized diallyl groups in PUFA, especially PUFA-PLS (PUFA-PE) containing phosphatidylethanolamine (PE)are most likely to undergo peroxidation under the catalysis of iron,which leads to the accumulation of a large amount of lipid peroxides in the cell membrane, cell membrane rupture and ferrodeath[40].Acyl-coa synthetase long-chain family member 4 (ACSL4) and lyso phosphatidylphosphatidyltransferase 3 (LPCAT3) are key enzymes in the synthesis of PUFA-PE[41, 42].ACSL4 can combine free PUFAs with coenzyme A (CoA) through acylation to form PUFA-CoA,which then occurs esterification under the action of LPCAT3 and reacts with PE to form PUFA-PE[43].Sha et al.collected biopsy specimens from 199 breast cancer patients who received paclitaxelcisplatin chemotherapy, and found that both ACSL4 expression and ACSL4/GPX4 combination status were independent predictors of achieving a pathological complete response (PCR) by rank test and Cox proportional regression.Moreover, ACSL4 expression is positively correlated with the overall survival rate of patients[44].The increased expression of ACSL4 in TNBC cell line MDA-MB-157 can enhance the sensitivity of cancer tissues to the ferroptosis inducer RSL3, while after knocking out ACSL4, cancer cells will not be induced to ferroptosis by RSL3, and the volume of cancer tissues in vivo becomes larger[45].These clues suggest that ACSL4 is a target for drug development in the treatment of TNBC.

    2.4 ACSL3/SCD1

    In contrast to ACSL4, MUFas such as octadecenoic acid mediated by ACSL3 or stearoyl-coa desaturase 1 (SCD1) competitively inhibit PUFA-related ferroptosis by substituting PLs in the cell membrane to form MUFA-PL.Studies have shown that inactivation of ACSL3 or SCD1 enhances the sensitivity of breast cancer cells to ferroptosis[46, 47].Luis et al.reported that SCD1 and fatty acid binding protein 4 (FABP4) were significantly up-regulated in human breast cancer specimens and were associated with poor prognosis in different types of breast cancer.Mechanistically, SCD1 can catalyze fatty acid desaturation and cooperate with FABP4 in the breast cancer microenvironment to promote lipid droplet formation,reduce hypoxia-induced ferroptosis, and promote cancer regrowth and recurrence.Down-regulation of SCD1 and FABP4 expression in vivo can significantly inhibit lipid transport in the cancer microenvironment and induce ferroptosis.Reduce the recurrence and metastasis of breast cancer[48].Cannabinoid receptor 1 (CB1)inhibitor rimonabant can activate PI3K and MAPK signaling pathways, reduce SCD1 and fatty acyl dessaturated enzyme 2(FADS2) -mediated MUFA production, promote ferroptosis of TNBC cells and the sensitivity of cancer tissues to Erastin and RSL3,and limit the growth of breast cancer tissues in vivo[49].Rimonabant may be an effective drug for the treatment of breast cancer, and the specific mechanism needs to be further confirmed.

    2.5 Nrf2

    Nuclear factor erythroid 2-related factor 2 (Nrf2) is a very important transcription factor for oxidative stress response, which can induce the expression of HO-1 and inhibit the expression of ROS, and exert anti-inflammatory and anti-ferroptosis effects.In recent years, it has been found that Nrf2 plays an important role in the progression,treatment and drug resistance of breast cancer.Jiang et al.found that TYRO3 expression in breast cancer tissues was associated with poor prognosis in breast cancer patients treated with anti-PD-1 /PD-L1 therapy.Mechanistically, anti-PD-1 /PD-L1 can induce a significant increase in TYRO3 expression in breast cancer tissues,further increase intracellular Nrf2 level, reduce ROS generation,and create a microenvironment conducive to tumor growth by inhibiting ferroptosis, making them resistant to anti-PD-1 /PDL1[50].Wu et al.reported that the expression of glycogen synthase kinase-3β (GSK-3β) was decreased, while Nrf2 was significantly overexpressed in breast cancer tissues.Overexpression of GSK-3β in TNBC cells inhibited Nrf2 expression, increased ROS and MDA content, and enhanced erastin-triggered ferroptosis.In the breast cancer xenograft model in vivo, overexpression of GSK-3β enhanced the effect of erastin-induced inhibition of tumor growth[51].Levistilide A, an active compound extracted from Ligusticum chuanxiong, can damage the mitochondrial structure and function of breast cancer cells by activating the Nrf2/HO-1 signaling pathway,and enhance ROS-induced ferroptosis in TNBC cells.Levistilide A may be a potential lead compound for breast cancer treatment[52].BET inhibitor (BETi) is a commonly used chemotherapeutic drug in the treatment of breast cancer, and its resistance is mainly mediated by NR5A2 and NCOA3.Mechanistically, NR5A2 interacts with NCOA3 to increase Nrf2 expression and inhibit ferroptosis in cancer cells.Inhibition of NR5A2 or NCOA3 using small molecule inhibitors can significantly enhance the anti-cancer effect of BETi on breast cancer in vitro and in vivo[53].

    2.6 FSP1-CoQH2

    Ferroptosis inhibitor protein 1 (FSP1), which inhibits ferroptosis independently of GPX4, is a flavoprotein encoded by a gene thought to be a p53-responsive gene[54], which is anchored to the cell membrane after N-terminal acylation and oxidize NAD(P)H to NAD(P)+ using FAD as a cofactor.At the same time, the generated reduced coenzyme Q (CoQH2) can reduce toxic lipid peroxides to non-toxic lipid alcohols[54], thereby inhibiting the process of lipid peroxidation and playing the role of anti-ferroptosis.FSP1 is a glutathione independent iron repressor[55] and a novel anti-ferroptosis biomarker[56].Silk fibroin nanoparticles coated with rosuvastatin can effectively inhibit the oxidoreductase activity of FSP1 and slow down the malignant progression of triple negative breast cancer[57].

    2.7 DHODH-CoQH2

    Dihydroorotate dehydrogenase (DHODH), which is present in the mitochondrial inner membrane, participates in the synthesis of pyrimidine and can reduce CoQ to CoQH2 in the mitochondrial inner membrane.When DHODH is activated, the production of CoQH2 increases, thereby inhibiting the process of lipid peroxidation in mitochondria[58], thus exerting an anti-ferroptosis effect.The DHODH inhibitor Breqinar selectively inhibits tumor growth with low GPX4 expression by inducing ferroptosis, while combination therapy with Breqinar and sulfasalazine synergistically induces ferroptosis and inhibits tumor growth with low GPX4 expression[58].DHODH inhibitor siR/IONs@LDH can induce ferroptosis in breast tumors[59].

    3.Summary and Prospect

    At present, targeted ferroptosis has been recognized as an effective method for the treatment of breast cancer, but its clinical application still faces many challenges.Firstly, most of the studies only carried out in vitro experiments, and the in vivo experiments were relatively ignored, so it is difficult to measure the effect of ferroptosis inducers on the growth and invasion of breast cancer tissues at the overall level.Moreover, the optimal dose of ferroptosis inducers in the treatment of breast cancer is rarely studied.Secondly, ferroptosis occurs not only in breast cancer tissues, but also in normal tissues.Therefore, ferroptosis inducers can not only kill tumor cells, but also cause harm to normal cells.TNBC is a type of breast cancer with the most difficult to treat and the highest recurrence rate in clinical practice.It has not been reported whether TNBC can be reedited to make it more sensitive to ferroptosis.Similar to the role of caspases, MLKL, GSDMs in other programmed death, what is the most representative marker of ferroptosis? Like other types of programmed cell death, ferroptosis has been found to play a doubleedged sword role in cancer, which depends on the release of damprelated molecular patterns in the tumor microenvironment and the activation of immune response triggered by ferroptosis damage.Therefore, how to reduce the side effects of ferroptosis inducers in the treatment of breast cancer is also an important problem.To solve these problems, future research should focus on both basic experiments and clinical trials, not only to explore the regulatory mechanism of ferroptosis, but also to pay attention to the changes in the function of various organs.It is possible to envisage that new treatment schemes designed for ferroptosis will be an important direction for the prevention and treatment of breast cancer in the future.

    色5月婷婷丁香| 欧美少妇被猛烈插入视频| 久久6这里有精品| 麻豆乱淫一区二区| 在线播放无遮挡| 国产免费一级a男人的天堂| 日日撸夜夜添| 亚洲国产最新在线播放| 久久久a久久爽久久v久久| 久久久久国产网址| 蜜臀久久99精品久久宅男| 在线观看三级黄色| 人妻人人澡人人爽人人| 老熟女久久久| 夫妻性生交免费视频一级片| 少妇丰满av| 久久综合国产亚洲精品| 国产亚洲一区二区精品| 日韩成人伦理影院| 一区二区三区精品91| 国国产精品蜜臀av免费| 亚洲精品成人av观看孕妇| 国产淫语在线视频| 午夜日本视频在线| 欧美性感艳星| 亚洲精品456在线播放app| 国产伦理片在线播放av一区| 亚洲精品视频女| 2018国产大陆天天弄谢| 国产精品久久久久久精品电影小说| 久久久国产欧美日韩av| .国产精品久久| 欧美bdsm另类| 热re99久久国产66热| 嘟嘟电影网在线观看| 欧美老熟妇乱子伦牲交| 少妇人妻一区二区三区视频| 精品少妇久久久久久888优播| 国产乱来视频区| 午夜视频国产福利| 国产亚洲5aaaaa淫片| 成人特级av手机在线观看| 精品一区二区三区视频在线| 美女中出高潮动态图| 欧美三级亚洲精品| 国产精品免费大片| 精品人妻熟女av久视频| 午夜免费观看性视频| 成人毛片60女人毛片免费| 黑人高潮一二区| 午夜老司机福利剧场| 乱人伦中国视频| 夫妻性生交免费视频一级片| 桃花免费在线播放| 老司机影院成人| 成人美女网站在线观看视频| 亚洲国产精品一区二区三区在线| 一级片'在线观看视频| 国产黄片视频在线免费观看| 晚上一个人看的免费电影| 一个人看视频在线观看www免费| 成人亚洲欧美一区二区av| 免费高清在线观看视频在线观看| 各种免费的搞黄视频| 成人漫画全彩无遮挡| 韩国av在线不卡| 欧美变态另类bdsm刘玥| 伊人亚洲综合成人网| 国产亚洲欧美精品永久| 一级黄片播放器| 人人妻人人看人人澡| 男女啪啪激烈高潮av片| 国产精品一区二区在线不卡| 日本黄色片子视频| 岛国毛片在线播放| 最新中文字幕久久久久| 91在线精品国自产拍蜜月| 另类精品久久| 亚洲欧美日韩东京热| 亚洲天堂av无毛| 黄色怎么调成土黄色| 特大巨黑吊av在线直播| 亚洲成色77777| 亚洲av成人精品一二三区| 亚洲国产最新在线播放| 欧美精品高潮呻吟av久久| 精品熟女少妇av免费看| 亚洲内射少妇av| 国产精品久久久久成人av| 亚洲第一av免费看| 亚洲av国产av综合av卡| 色视频在线一区二区三区| 国产一级毛片在线| 99视频精品全部免费 在线| av免费在线看不卡| 老司机影院成人| 人妻 亚洲 视频| 亚洲精品aⅴ在线观看| 免费久久久久久久精品成人欧美视频 | 免费黄频网站在线观看国产| 免费观看av网站的网址| 亚洲欧洲精品一区二区精品久久久 | 亚洲国产最新在线播放| 精品一品国产午夜福利视频| 午夜日本视频在线| 久久久久久久精品精品| 中文在线观看免费www的网站| 寂寞人妻少妇视频99o| 日韩av免费高清视频| 最近2019中文字幕mv第一页| 人人妻人人爽人人添夜夜欢视频 | 国产美女午夜福利| 日本黄色日本黄色录像| 又大又黄又爽视频免费| 在线 av 中文字幕| 麻豆成人av视频| 69精品国产乱码久久久| 一本久久精品| 国产在线男女| 精品国产乱码久久久久久小说| 欧美日韩国产mv在线观看视频| 亚洲国产毛片av蜜桃av| 国产极品天堂在线| 热re99久久国产66热| 国产精品麻豆人妻色哟哟久久| 国产女主播在线喷水免费视频网站| 夫妻午夜视频| 狠狠精品人妻久久久久久综合| 成人免费观看视频高清| 九色成人免费人妻av| 一级黄片播放器| www.av在线官网国产| 精品一区二区免费观看| 狂野欧美白嫩少妇大欣赏| 尾随美女入室| 日日撸夜夜添| 国产精品一二三区在线看| 国产成人freesex在线| 亚洲av男天堂| 少妇熟女欧美另类| 黄色日韩在线| 亚洲精品国产成人久久av| 亚洲成人一二三区av| 黄色日韩在线| 搡老乐熟女国产| 妹子高潮喷水视频| 久久人妻熟女aⅴ| 亚洲欧洲精品一区二区精品久久久 | 熟女人妻精品中文字幕| 国产欧美亚洲国产| 精品久久国产蜜桃| 男人狂女人下面高潮的视频| 一级毛片黄色毛片免费观看视频| 有码 亚洲区| 男人狂女人下面高潮的视频| 全区人妻精品视频| a级毛片免费高清观看在线播放| 妹子高潮喷水视频| 人妻夜夜爽99麻豆av| 9色porny在线观看| 久久久久久久亚洲中文字幕| 国产精品国产三级专区第一集| 国精品久久久久久国模美| 国产色爽女视频免费观看| 久久久久久久久久久久大奶| 18禁在线播放成人免费| 极品少妇高潮喷水抽搐| 亚洲av欧美aⅴ国产| 亚洲情色 制服丝袜| 99热这里只有精品一区| 我的老师免费观看完整版| 精品一区在线观看国产| 中文字幕免费在线视频6| av.在线天堂| 成人18禁高潮啪啪吃奶动态图 | 久久婷婷青草| 哪个播放器可以免费观看大片| 精品国产国语对白av| 青春草视频在线免费观看| 亚洲精品,欧美精品| 亚洲婷婷狠狠爱综合网| 亚洲精品一二三| 免费播放大片免费观看视频在线观看| 99热6这里只有精品| av有码第一页| 国产日韩一区二区三区精品不卡 | 亚洲丝袜综合中文字幕| 美女主播在线视频| 国产成人aa在线观看| 亚洲欧美日韩东京热| 国产精品人妻久久久影院| 韩国高清视频一区二区三区| 黄色一级大片看看| 自拍欧美九色日韩亚洲蝌蚪91 | 七月丁香在线播放| 女的被弄到高潮叫床怎么办| 91久久精品电影网| av在线播放精品| 国产精品麻豆人妻色哟哟久久| 久久99蜜桃精品久久| 精品国产国语对白av| 另类亚洲欧美激情| 欧美bdsm另类| 99热这里只有是精品在线观看| 女人久久www免费人成看片| 高清av免费在线| 美女视频免费永久观看网站| 永久免费av网站大全| 欧美日韩视频高清一区二区三区二| 久久久久久久久久久丰满| 日韩一本色道免费dvd| 久久 成人 亚洲| 美女中出高潮动态图| 蜜臀久久99精品久久宅男| 六月丁香七月| 亚洲性久久影院| 草草在线视频免费看| 51国产日韩欧美| 国产精品.久久久| 多毛熟女@视频| 亚洲精品国产av蜜桃| 日韩欧美 国产精品| 久久6这里有精品| h视频一区二区三区| 日韩中字成人| 精品人妻熟女av久视频| 成年美女黄网站色视频大全免费 | 亚洲国产欧美日韩在线播放 | 国产无遮挡羞羞视频在线观看| 黄色日韩在线| 97超视频在线观看视频| 久久久久久久大尺度免费视频| 日本-黄色视频高清免费观看| 国产综合精华液| 国产一区有黄有色的免费视频| av免费观看日本| 人妻少妇偷人精品九色| 插逼视频在线观看| 久久6这里有精品| av视频免费观看在线观看| 精品国产一区二区久久| 妹子高潮喷水视频| 最新的欧美精品一区二区| 亚洲欧美清纯卡通| 日韩熟女老妇一区二区性免费视频| av一本久久久久| 丁香六月天网| 又大又黄又爽视频免费| 午夜激情福利司机影院| 高清午夜精品一区二区三区| 国产精品女同一区二区软件| 精品一区二区三卡| 日韩不卡一区二区三区视频在线| 国产中年淑女户外野战色| 欧美区成人在线视频| 国产精品欧美亚洲77777| av黄色大香蕉| 26uuu在线亚洲综合色| 最近2019中文字幕mv第一页| 寂寞人妻少妇视频99o| 卡戴珊不雅视频在线播放| 另类亚洲欧美激情| 黑人高潮一二区| 亚洲精品国产av蜜桃| 日韩一本色道免费dvd| 一级毛片我不卡| 人妻一区二区av| 又粗又硬又长又爽又黄的视频| 亚洲国产成人一精品久久久| av播播在线观看一区| 在现免费观看毛片| 国产白丝娇喘喷水9色精品| 91久久精品国产一区二区三区| 日本91视频免费播放| 国产一区二区在线观看日韩| 97精品久久久久久久久久精品| 99精国产麻豆久久婷婷| 最近中文字幕高清免费大全6| 少妇的逼水好多| 亚洲国产欧美在线一区| av在线app专区| 欧美日韩视频精品一区| 国产精品国产三级国产专区5o| 亚洲第一区二区三区不卡| 天堂8中文在线网| 国产免费又黄又爽又色| 亚洲综合色惰| 十八禁高潮呻吟视频 | 国产成人精品一,二区| 日韩不卡一区二区三区视频在线| 香蕉精品网在线| 精品人妻偷拍中文字幕| 国产精品熟女久久久久浪| 亚洲经典国产精华液单| a级毛片免费高清观看在线播放| 一级爰片在线观看| 黑人高潮一二区| 久久久久久久久久久丰满| av免费观看日本| a级毛色黄片| 国产永久视频网站| 丝袜脚勾引网站| 国产av码专区亚洲av| 91久久精品国产一区二区成人| 麻豆成人av视频| av一本久久久久| 精品一区二区三卡| 一边亲一边摸免费视频| 老女人水多毛片| 国产极品粉嫩免费观看在线 | 国产色爽女视频免费观看| 少妇人妻 视频| 久久精品久久久久久久性| 久久久亚洲精品成人影院| 高清欧美精品videossex| 国产白丝娇喘喷水9色精品| 日韩成人av中文字幕在线观看| 国产成人午夜福利电影在线观看| 免费久久久久久久精品成人欧美视频 | 丰满乱子伦码专区| 精品一区二区三卡| 亚州av有码| 极品少妇高潮喷水抽搐| 桃花免费在线播放| av在线老鸭窝| 777米奇影视久久| 国产高清三级在线| 各种免费的搞黄视频| 亚洲国产精品国产精品| 日本wwww免费看| 晚上一个人看的免费电影| 欧美精品一区二区免费开放| 99热这里只有是精品在线观看| 久久免费观看电影| 一级黄片播放器| 22中文网久久字幕| 欧美xxxx性猛交bbbb| 国产免费福利视频在线观看| 我要看黄色一级片免费的| 国产精品一区二区在线观看99| 久久6这里有精品| 精品人妻熟女毛片av久久网站| 噜噜噜噜噜久久久久久91| 久久婷婷青草| 丰满乱子伦码专区| 国产精品不卡视频一区二区| 国产亚洲最大av| 久久婷婷青草| av一本久久久久| 国产在线男女| 丰满迷人的少妇在线观看| 成人午夜精彩视频在线观看| 成人特级av手机在线观看| 秋霞伦理黄片| 欧美少妇被猛烈插入视频| 久热这里只有精品99| 一级a做视频免费观看| videos熟女内射| 九九久久精品国产亚洲av麻豆| 亚洲av不卡在线观看| 深夜a级毛片| 免费观看无遮挡的男女| 国产在线免费精品| 午夜福利视频精品| 国产高清不卡午夜福利| 好男人视频免费观看在线| 五月开心婷婷网| 午夜福利视频精品| 欧美日韩综合久久久久久| 久久午夜福利片| h日本视频在线播放| 日日摸夜夜添夜夜爱| 国产在线免费精品| av国产久精品久网站免费入址| 国产高清不卡午夜福利| 插阴视频在线观看视频| 午夜福利在线观看免费完整高清在| 国产在视频线精品| 两个人的视频大全免费| 在线免费观看不下载黄p国产| 亚洲精品乱码久久久久久按摩| 水蜜桃什么品种好| 免费人妻精品一区二区三区视频| 91精品国产九色| 久久精品国产自在天天线| 精品99又大又爽又粗少妇毛片| 欧美日韩精品成人综合77777| 亚洲国产成人一精品久久久| 亚洲伊人久久精品综合| 又黄又爽又刺激的免费视频.| 大码成人一级视频| 一级毛片aaaaaa免费看小| 欧美国产精品一级二级三级 | 热re99久久国产66热| 夫妻性生交免费视频一级片| 欧美 亚洲 国产 日韩一| 制服丝袜香蕉在线| 国产黄色视频一区二区在线观看| 国产黄色免费在线视频| 成人二区视频| 99热国产这里只有精品6| 丝瓜视频免费看黄片| 草草在线视频免费看| 涩涩av久久男人的天堂| av又黄又爽大尺度在线免费看| 国产一区有黄有色的免费视频| 国产亚洲91精品色在线| 国产精品人妻久久久久久| 人人澡人人妻人| 99re6热这里在线精品视频| 亚洲欧美日韩卡通动漫| 色网站视频免费| 高清欧美精品videossex| 成人毛片60女人毛片免费| 国产黄色视频一区二区在线观看| 91aial.com中文字幕在线观看| 特大巨黑吊av在线直播| 亚洲av.av天堂| 在线观看人妻少妇| 亚洲内射少妇av| 国产精品人妻久久久久久| 视频中文字幕在线观看| 女性生殖器流出的白浆| 春色校园在线视频观看| 一级,二级,三级黄色视频| 国产69精品久久久久777片| 最黄视频免费看| 久久久久久人妻| 亚洲伊人久久精品综合| 美女中出高潮动态图| 国产亚洲最大av| 国产精品99久久久久久久久| 国产成人免费无遮挡视频| 国产av精品麻豆| 久久久久网色| 亚洲精品久久久久久婷婷小说| 色视频www国产| 99热国产这里只有精品6| 国产日韩欧美亚洲二区| 免费不卡的大黄色大毛片视频在线观看| 美女中出高潮动态图| 成人影院久久| 亚洲国产日韩一区二区| 日韩免费高清中文字幕av| 亚洲av欧美aⅴ国产| 人妻系列 视频| 日本av免费视频播放| 亚洲精品乱码久久久v下载方式| 各种免费的搞黄视频| 成人午夜精彩视频在线观看| 啦啦啦中文免费视频观看日本| .国产精品久久| 性色avwww在线观看| 亚洲av日韩在线播放| 少妇熟女欧美另类| 视频区图区小说| 丁香六月天网| av一本久久久久| 国产在线视频一区二区| 插阴视频在线观看视频| 男人舔奶头视频| 欧美日韩亚洲高清精品| 一级毛片 在线播放| 日韩欧美一区视频在线观看 | av天堂中文字幕网| 国产老妇伦熟女老妇高清| 午夜日本视频在线| 亚洲美女搞黄在线观看| 777米奇影视久久| 国产精品不卡视频一区二区| 热re99久久国产66热| 在线看a的网站| 国产视频内射| 视频区图区小说| 国产色婷婷99| 99九九线精品视频在线观看视频| 另类精品久久| 亚洲欧美成人综合另类久久久| 在线观看人妻少妇| 久久ye,这里只有精品| 国产成人freesex在线| 插阴视频在线观看视频| 日日啪夜夜撸| 精品99又大又爽又粗少妇毛片| 国产一区亚洲一区在线观看| 蜜桃在线观看..| 91精品伊人久久大香线蕉| 久久99一区二区三区| 人妻系列 视频| 草草在线视频免费看| 久久狼人影院| 天堂8中文在线网| 亚洲成人av在线免费| 简卡轻食公司| 欧美bdsm另类| 成年女人在线观看亚洲视频| 色视频在线一区二区三区| 国产av码专区亚洲av| 99热6这里只有精品| 日韩不卡一区二区三区视频在线| 久久精品熟女亚洲av麻豆精品| 黄色怎么调成土黄色| 日本免费在线观看一区| 日本黄色片子视频| 日韩大片免费观看网站| 中文资源天堂在线| av国产久精品久网站免费入址| 国产永久视频网站| 中文字幕免费在线视频6| 中文精品一卡2卡3卡4更新| 久久av网站| 亚洲婷婷狠狠爱综合网| 亚洲精品视频女| 九九爱精品视频在线观看| 有码 亚洲区| 黄色一级大片看看| 丝袜脚勾引网站| 欧美bdsm另类| 久久这里有精品视频免费| 日日摸夜夜添夜夜爱| 国产女主播在线喷水免费视频网站| 嘟嘟电影网在线观看| 国产欧美另类精品又又久久亚洲欧美| 伦精品一区二区三区| 亚洲精品国产av成人精品| 亚洲av中文av极速乱| 久久久久久人妻| 多毛熟女@视频| 看十八女毛片水多多多| 简卡轻食公司| 亚洲av成人精品一二三区| 80岁老熟妇乱子伦牲交| 国产免费视频播放在线视频| 成人毛片a级毛片在线播放| 纯流量卡能插随身wifi吗| 免费久久久久久久精品成人欧美视频 | 国产免费一区二区三区四区乱码| 伊人亚洲综合成人网| 成年av动漫网址| 欧美国产精品一级二级三级 | 国产 精品1| 亚洲欧洲国产日韩| 国产成人午夜福利电影在线观看| 丰满少妇做爰视频| 日本与韩国留学比较| 又黄又爽又刺激的免费视频.| 欧美日韩视频高清一区二区三区二| 免费观看在线日韩| 国产无遮挡羞羞视频在线观看| 国产欧美另类精品又又久久亚洲欧美| 国产探花极品一区二区| 国产淫片久久久久久久久| 日本午夜av视频| 精品久久久噜噜| 国精品久久久久久国模美| 边亲边吃奶的免费视频| 丝瓜视频免费看黄片| 久久ye,这里只有精品| 精品国产露脸久久av麻豆| 啦啦啦啦在线视频资源| 亚洲精品乱久久久久久| 一个人看视频在线观看www免费| 五月天丁香电影| 久久精品久久久久久噜噜老黄| 久久婷婷青草| videossex国产| 亚洲精品久久久久久婷婷小说| 国产亚洲av片在线观看秒播厂| 成人漫画全彩无遮挡| 制服丝袜香蕉在线| 狠狠精品人妻久久久久久综合| 久久久精品94久久精品| 熟女电影av网| 极品教师在线视频| 欧美少妇被猛烈插入视频| 国产av精品麻豆| 免费看日本二区| 有码 亚洲区| 国产高清不卡午夜福利| 妹子高潮喷水视频| 国产男女内射视频| 三级经典国产精品| 秋霞在线观看毛片| 日韩中文字幕视频在线看片| 国产探花极品一区二区| 观看av在线不卡| 久久狼人影院| videossex国产| 欧美日韩在线观看h| 在线观看一区二区三区激情| 啦啦啦视频在线资源免费观看| 男人舔奶头视频| 国产一区有黄有色的免费视频| 久久6这里有精品| 婷婷色麻豆天堂久久| 国产色爽女视频免费观看| 亚洲欧美日韩卡通动漫| 久久久午夜欧美精品| 日本91视频免费播放| 高清不卡的av网站| 国产精品国产三级专区第一集| 国产日韩欧美在线精品| 毛片一级片免费看久久久久| 久久久午夜欧美精品| 国产色婷婷99| 久久午夜福利片| 亚洲天堂av无毛| 少妇被粗大的猛进出69影院 | 大码成人一级视频| 久久久国产精品麻豆| 国产乱来视频区| 国产亚洲欧美精品永久| 色网站视频免费| 欧美日韩亚洲高清精品| 久久久久人妻精品一区果冻|